These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9103207)

  • 1. New era in breast cancer. Impact of screening on disease presentation.
    Cady B
    Surg Oncol Clin N Am; 1997 Apr; 6(2):195-202. PubMed ID: 9103207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening.
    Cady B; Stone MD; Schuler JG; Thakur R; Wanner MA; Lavin PT
    Arch Surg; 1996 Mar; 131(3):301-8. PubMed ID: 8611096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased mammography use and its impact on earlier breast cancer detection in Vermont, 1975-1999.
    Vacek PM; Geller BM; Weaver DL; Foster RS
    Cancer; 2002 Apr; 94(8):2160-8. PubMed ID: 12001112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic possibilities in primary invasive breast cancer.
    Cady B; Stone MD; Wayne J
    Ann Surg; 1993 Sep; 218(3):338-47; discussion 347-9. PubMed ID: 8373276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection and diagnosis of early, occult and minimal breast cancer.
    Hickey RC; Gallager HS; Dodd GD; Samuels BI; Paulus DD; Moore DL
    Adv Surg; 1976; 10():287-312. PubMed ID: 185891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Herrada J; Iyer RB; Atkinson EN; Sneige N; Buzdar AU; Hortobagyi GN
    Clin Cancer Res; 1997 Sep; 3(9):1565-9. PubMed ID: 9815844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma.
    Huston TL; Pressman PI; Moore A; Vahdat L; Hoda SA; Kato M; Weinstein D; Tousimis E
    Breast J; 2007; 13(2):158-64. PubMed ID: 17319857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.
    Kapoor NS; Shamonki J; Sim MS; Chung CT; Giuliano AE
    Ann Surg Oncol; 2013 Aug; 20(8):2576-81. PubMed ID: 23468047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do mammographic tumor features in breast cancer relate to breast density and invasiveness, tumor size, and axillary lymph node involvement?
    Sartor H; Borgquist S; Hartman L; Olsson Å; Jawdat F; Zackrisson S
    Acta Radiol; 2015 May; 56(5):536-44. PubMed ID: 24814360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubular carcinoma of the breast: mode of presentation, mammographic appearance, and frequency of nodal metastases.
    Elson BC; Helvie MA; Frank TS; Wilson TE; Adler DD
    AJR Am J Roentgenol; 1993 Dec; 161(6):1173-6. PubMed ID: 8249721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].
    Modesto A; Gandy C; Mery E; Filleron T; Massabeau C; Izar F; Charitansky H; Roché H; de Lafontan B
    Cancer Radiother; 2014 Mar; 18(2):107-10. PubMed ID: 24637020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
    Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
    Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.